All Nippon Airways’ New Airbus A380 Aircraft Take Flight with Mobil JetTM Oil 387
ExxonMobil announced today that All Nippon Airways (ANA) is now using Mobil JetTM Oil 387
News
Judge Selects Lieff Cabraser Partner Kenny Byrd to Serve in Leadership Role on Early Vetting Committee in Nationwide 3M Combat Arms Earplug Defects Hearing Damage Litigation
On May 22, 2019, Judge M. Casey Rodgers of the U.S. District Court for the
JDA Again Named a Leader in Three Gartner Supply Chain Magic Quadrants
JDA Software, Inc. announced it has once again been positioned by Gartner, Inc. in the
Symantec Named a Leader in Enterprise Email Security by Independent Research Firm
Symantec Corporation (NASDAQ: SYMC), the worlds leading cyber security company, today announced that it has
Insperity Declares Quarterly Dividend of $0.30
Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for
New York Digital USD Stablecoin DUSD Exclusively Named FINWISE Summit Hong Kong Station
HONG KONG, CHINA – Media_OutReach – 24 May 2019 – Abstract: Johnson Zhao, founder of Wall Street Finance, has created a 100%
Argo Group Issues $0.31 Per Share Cash Dividend
Argo Group International Holdings, Ltd. (NYSE: ARGO), an international underwriter of specialty insurance and reinsurance
Options Announces Strategic Partnership with Darktrace
Options, the leading provider of cloud-enabled managed services to the global capital markets, has today
Medidata to Present Breakthrough Innovation at 2019 ASCO Annual Meeting
For the third consecutive year, Medidata (NASDAQ: MDSO) will present breakthrough scientific findings at the
Cemtrex Announces Reverse Split to Regain NASDAQ Compliance
Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology company, today announced that effective
NeoImmuneTech Announces that the FDA has Allowed the Center for Cancer Research, National Cancer Institute to Proceed with an Investigational New Drug Application to Initiate a Clinical Trial for Hyleukin-7™ with Vaccines in Elderly Cancer Survivors
NeoImmuneTech, Inc. (NIT), a T cell-focused immunotherapeutics company, today announced that the U.S. Food and
AM Best Associate Director to Join Session at Annual Strategic Risk Solutions Symposium
AM Best will participate in the Strategic Risk Solutions client symposium, which taking place May
